Publications by authors named "Daisy Moreno"

Claim this Profile
D
Discovery and characterization of novel mutant FLT3 kinase inhibitors.
Ellen Weisberg, Hwan Geun Choi, Rosemary Barrett, Wenjun Zhou, Jianming Zhang, Daisy Moreno

Mol Cancer Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants.
Ellen Weisberg, Hwan Geun Choi, Arghya Ray, Rosemary Barrett, Jianming Zhang, Daisy Moreno

Blood· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells.
Ellen Weisberg, Johannes Roesel, Guido Bold, Pascal Furet, Jingrui Jiang, Daisy Moreno

Blood· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
Ellen Weisberg, Lolita Banerji, Renee D Wright, Rosemary Barrett, Arghya Ray, Daisy Moreno

Blood· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.
Xavier Leleu, Xiaoying Jia, Judith Runnels, Hai T Ngo, Anne-Sophie Moreau, Daisy Moreno

Blood· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells.
Ellen Weisberg, Andrew L Kung, Renee D Wright, Daisy Moreno, Laurie Catley

Mol Cancer Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias.
Ellen Weisberg, Laurie Catley, Renee D Wright, Daisy Moreno, Lolita Banerji

Blood· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity.
Ellen Weisberg, Renee D Wright, Jingrui Jiang, Arghya Ray, Daisy Moreno

Gastroenterology· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis